Insider’s View: Deciphering Inovio Pharmaceuticals Inc (INO)’s Financial Health Through Ratios

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Inovio Pharmaceuticals Inc (NASDAQ: INO) closed at $5.49 in the last session, down -3.51% from day before closing price of $5.69. In other words, the price has decreased by -$3.51 from its previous closing price. On the day, 0.53 million shares were traded. INO stock price reached its highest trading level at $5.77 during the session, while it also had its lowest trading level at $5.38.

Ratios:

We take a closer look at INO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.45 and its Current Ratio is at 4.45. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.11.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on May 14, 2024, initiated with a Overweight rating and assigned the stock a target price of $20.

On January 25, 2024, Oppenheimer Upgraded its rating to Outperform which previously was Perform but kept the price unchanged to $4.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INO now has a Market Capitalization of 142544000 and an Enterprise Value of 45102524. For the stock, the TTM Price-to-Sale (P/S) ratio is 241.56 while its Price-to-Book (P/B) ratio in mrq is 1.47. Its current Enterprise Value per Revenue stands at 76.205 whereas that against EBITDA is -0.392.

Stock Price History:

Over the past 52 weeks, INO has reached a high of $14.75, while it has fallen to a 52-week low of $3.89. The 50-Day Moving Average of the stock is -22.27%, while the 200-Day Moving Average is calculated to be -38.54%.

Shares Statistics:

According to the various share statistics, INO traded on average about 324.37K shares per day over the past 3-months and 428470 shares per day over the past 10 days. A total of 25.96M shares are outstanding, with a floating share count of 25.74M. Insiders hold about 0.85% of the company’s shares, while institutions hold 31.20% stake in the company. Shares short for INO as of 1726185600 were 3050539 with a Short Ratio of 9.40, compared to 1723680000 on 2920791. Therefore, it implies a Short% of Shares Outstanding of 3050539 and a Short% of Float of 11.83.

Most Popular